| [1] |
Nie JJ, Sun KX, Li J, et al. A type-specific nested PCR assay established and applied for investigation of HBV genotype and subgenotype in Chinese patients with chronic HBV infection. Virol J, 2012,9(1):121.
|
| [2] |
Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities——Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep, 2005, 54(9):220-223.
|
| [3] |
Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Morb Mortal Wkly Rep, 2005, 54(RR-16):1-31.
|
| [4] |
Alter HJ, Purcell RH, Gerin JL, et al. Transmission of hepatitis B to chimpanzees by hepatitis surface antigen-positive saliva and semen. Infect Immun, 1977, 16(3):928-933.
|
| [5] |
Bancroft WH, Snitbhan R, Scott RM, et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis, 1977, 135(1):79-85.
|
| [6] |
Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Recomm Rep, 2006,55(RR-16):1-33.
|
| [7] |
Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic-acid amplification testing. National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. N Engl J Med, 2004, 351(8):760-768.
|
| [8] |
Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med, 1996, 334(26):1685-1690.
|
| [9] |
American Association of Blood Banks. Transfusion-transmitted diseases. Bethesda(MD)：AABB；2005.Availableat:
URL
|
| [10] |
梁晓峰，陈园生，王晓军．中国3岁以上人群乙型肝炎血清流行病学研究．中华流行病学杂志，2005,26(9):655-658.
|
| [11] |
Centers for Disease Control and Prevention. Recommended adult immunization schedule: United States, October 2006-September 2007. Atlanta (GA): CDC, 2006. Available at:
URL
|
| [12] |
Connor BA, Blatter MM, Beran J, et al. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. J Trav Med, 2007, 14(1):9-15.
|
| [13] |
Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep, 2006, 55(RR-11):1-94.
|
| [14] |
Van Herck K, Leroux-Roels G, Van Damme P, et al. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.Travel Med Infect Dis，2007, 5(3):171-175.
|
| [15] |
Hewlett AT. Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis. Expert Opin Biol Ther, 2009,9(9):1235-1240.
|
| [16] |
Recommendations for prevention and control of hepatitis C (virus HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998, 47(RR-19):1-39.
|
| [17] |
American Academy of Pediatrics. Red book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village (IL): AAP: 2006.
|
| [18] |
中华医学会肝病学分会，中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版). 临床肝胆杂志，2011, 27(1):1-16.
|
| [19] |
Silverman NS, Darby MJ, Ronkin SL, et al. Hepatitis B prevalence in an unregistered prenatal population. Implications for neonatal therapy. JAMA, 1991, 266(20):2852-2855.
|
| [20] |
Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol, 2002, 67(1):20-26.
|
| [21] |
Yang J, Zeng XM, Men YL, et al. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus－－a systematic review. Virol J, 2008, 5,100.
|
| [22] |
Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol, 2001, 184(7):1514-1518.
|
| [23] |
Alexander JM, Ramus R, Jackson G, et al. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol, 1999, 7(6):283-286.
|
| [24] |
Grosheide PM, Quartero HW, Schalm SW, et al. Early invasive prenatal diagnosis in HBsAg-positive women. Prenat Diagn, 1994, 14(7):553-558.
|
| [25] |
Ko TM, Tseng LH, Chang MH, et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection. Arch Gynecol Obstet, 1994, 255(1):25-30.
|
| [26] |
López M, Coll O. Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther, 2010, 28(1):1-8.
|
| [27] |
Shi Z, Yang Y, Wang H, et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med, 2011,165(9):837-846.
|
| [28] |
Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat, 2009, 16(2):94-103.
|
| [29] |
van Zonneveld M, van Nunen AB, Niesters HG, et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat, 2003, 10(4):294-297.
|
| [30] |
Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol, 2004, 10(21):3215-3217.
|
| [31] |
Zhu Q, Yu G, Yu H, et al. A randomized controlled trial on interruption of HBV transmission in utero. Chinese Med J, 2003, 116(5):685-687.
|
| [32] |
Bzowej NH. Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant. Curr Hepat Rep, 2012, 11(2):82-89.
|
| [33] |
Pol S, Corouge M, Fontaine H. Hepatitis B virus infection and pregnancy. Clin Res Hepatol Gastroenterol, 2011, 35(10):618-622.
|
| [34] |
Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antivir Ther, 2011,16(5):621-628.
|
| [35] |
U．S. Public Health Service. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep, 2001,50(RR-11):1-52.
|